Each week the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Pharmaceutical company Daiichi Sankyo made a $10m pledge yesterday to Hatch Biofund 1, a US-based venture capital fund formed by non-profit medical research organisation Baruch S. Blumberg Institute. Hatch Biofund has a $50m target for its close, and Daiichi Sankyo’s commitment was made in connection with a collaboration agreement with life sciences incubator Pennsylvania Biotechnology Center.
Japan-headquartered crowdfunding platform operator ReadyFor secured ¥1bn ($9.1m) in series B funding on Monday from investors including Globis Capital Partners, Salesforce Ventures, Mitsubishi UFJ…
